CD8A and neoplasm: Furthermore, FABP5 deletion potentiates RFA‐induced ferroptosis and bolsters anti‐tumor immune responses, characterized by increased infiltration of CD8+ T cells and effector memory T cells, contributing to pronounced systemic anti‐tumor effects.